Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

UBT251

A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight

The United Bio-Technology (Hengqin) Co · Phase 1 · Recruiting · Enrollment 44

NCT07710768

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
UBT251n/rn/rn/rn/r
Cocktail (Warfarin/Caffeine/Midazolam)n/rn/rn/rn/r

Not shown

  • UBT251: endpoint not reported
  • Cocktail (Warfarin/Caffeine/Midazolam): endpoint not reported